Company / R&D per Share
Amphstar Pharmaceuticals, Inc. R&D per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D per Share
$1.80
FY2025
5-year range
$1.28 / $1.80
FY2021-FY2025
Trend
+17.2%
vs FY2024
Sector context
#112 of 208
Health Care
What the data says
At $1.80, Amphstar Pharmaceuticals, Inc.'s r&d per share ranks #112 of 208 in the Health Care sector. R&D per Share has fluctuated over the past 10 years, ranging from $0.92 in FY2016 to $1.80 in FY2025.
Based on SEC 10-K filings.
1.80 in FY2025 with a 5-year CAGR of +4.5%.
Improved from $1.53 to $1.80 over the past 2 years.
Health Care sector context is included.
R&D per Share over time
Growth rates
- 3-Year CAGR
- +4.8%
- 5-Year CAGR
- +4.5%
- 10-Year CAGR
- -
Sector benchmark
#112 of 208 in Health CareTop 54% of 208This company $1.80 Sector average $28.82
▼
-93.7% below sector average
Key checks
Key Insights
- In FY2025, r&d per share increased 17.2% year-over-year.
- Ranks #112 out of 208 companies in the Health Care sector.
- Lowest r&d per share in the period was in FY2016.
Company context
Key Data Points
- Strong profit margin: 21.8%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.80 | +17.2% |
| FY2024 | $1.54 | +0.3% |
| FY2023 | $1.53 | -2.2% |
| FY2022 | $1.57 | +22.1% |
| FY2021 | $1.28 | -11.1% |
| FY2020 | $1.44 | -2.2% |
| FY2019 | $1.48 | +19.6% |
| FY2018 | $1.23 | +31.3% |
| FY2017 | $0.94 | +2.4% |
| FY2016 | $0.92 | +10.0% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026